212 related articles for article (PubMed ID: 36960049)
1. PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis.
Pereira JA; Lanzar Z; Clark JT; Hart AP; Douglas BB; Shallberg L; O'Dea K; Christian DA; Hunter CA
Front Immunol; 2023; 14():997376. PubMed ID: 36960049
[TBL] [Abstract][Full Text] [Related]
2. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
3. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
4. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
Panda AK; Kim YH; Shevach EM
J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
[TBL] [Abstract][Full Text] [Related]
5. PD-1
Kamada T; Togashi Y; Tay C; Ha D; Sasaki A; Nakamura Y; Sato E; Fukuoka S; Tada Y; Tanaka A; Morikawa H; Kawazoe A; Kinoshita T; Shitara K; Sakaguchi S; Nishikawa H
Proc Natl Acad Sci U S A; 2019 May; 116(20):9999-10008. PubMed ID: 31028147
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
[TBL] [Abstract][Full Text] [Related]
7. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
Holt MP; Punkosdy GA; Glass DD; Shevach EM
J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
[TBL] [Abstract][Full Text] [Related]
8. PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection.
Perry JA; Shallberg L; Clark JT; Gullicksrud JA; DeLong JH; Douglas BB; Hart AP; Lanzar Z; O'Dea K; Konradt C; Park J; Kuchroo JR; Grubaugh D; Zaretsky AG; Brodsky IE; Malefyt RW; Christian DA; Sharpe AH; Hunter CA
Nat Immunol; 2022 May; 23(5):743-756. PubMed ID: 35437326
[TBL] [Abstract][Full Text] [Related]
9. PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice.
Frijlink E; Bosma DM; Busselaar J; Battaglia TW; Staal MD; Verbrugge I; Borst J
J Clin Invest; 2024 Feb; 134(6):. PubMed ID: 38349740
[TBL] [Abstract][Full Text] [Related]
10. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M
Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845
[TBL] [Abstract][Full Text] [Related]
11. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
[TBL] [Abstract][Full Text] [Related]
12. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
Ovcinnikovs V; Ross EM; Petersone L; Edner NM; Heuts F; Ntavli E; Kogimtzis A; Kennedy A; Wang CJ; Bennett CL; Sansom DM; Walker LSK
Sci Immunol; 2019 May; 4(35):. PubMed ID: 31152091
[TBL] [Abstract][Full Text] [Related]
14. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
Asano T; Meguri Y; Yoshioka T; Kishi Y; Iwamoto M; Nakamura M; Sando Y; Yagita H; Koreth J; Kim HT; Alyea EP; Armand P; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Maeda Y; Tanimoto M; Ritz J; Matsuoka KI
Blood; 2017 Apr; 129(15):2186-2197. PubMed ID: 28151427
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
Chattopadhyay G; Shevach EM
J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
[TBL] [Abstract][Full Text] [Related]
16. CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
Soskic B; Jeffery LE; Kennedy A; Gardner DH; Hou TZ; Halliday N; Williams C; Janman D; Rowshanravan B; Hirschfield GM; Sansom DM
Front Immunol; 2020; 11():577655. PubMed ID: 33488578
[TBL] [Abstract][Full Text] [Related]
17. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Analysis of CTLA-4-Mediated Transendocytosis by Regulatory T Cells.
Waters E; Williams C; Kennedy A; Sansom DM
Methods Mol Biol; 2023; 2559():171-187. PubMed ID: 36180633
[TBL] [Abstract][Full Text] [Related]
19. Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation.
Xu Z; Tsai HI; Xiao Y; Wu Y; Su D; Yang M; Zha H; Yan F; Liu X; Cheng F; Chen H
ACS Nano; 2020 Jul; 14(7):7959-7969. PubMed ID: 32515579
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration.
Piao W; Li L; Saxena V; Iyyathurai J; Lakhan R; Zhang Y; Lape IT; Paluskievicz C; Hippen KL; Lee Y; Silverman E; Shirkey MW; Riella LV; Blazar BR; Bromberg JS
Nat Commun; 2022 Apr; 13(1):2176. PubMed ID: 35449134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
